On Feb. 27, Gordon & Rees San Francisco partner Kai Peters will present at the American Bar Association’s Life Sciences Legal Summit on the topic of regulatory strategies, risk minimization, and post-marketing strategies for life science companies.
Peters' panel will discuss how developing successful strategies for pharmaceutical and medical device products can help clients maximize their commercial opportunities while minimizing risk. He will examine vital regulatory strategy subjects, standards, and risk tools for use with FDA-regulated pharmaceutical and medical device manufacturers.
The Life Sciences Legal Summit – to be held at Genentech in South San Francisco – features pre-eminent attorneys, industry figures, leading trial and appellate lawyers, and in-house counsel. Attendees will hear the latest on cutting-edge legal and technical issues relevant to those practicing in pharmaceutical, medical device, and biotechnology arenas.
Peters is a member of Gordon & Rees’s Drug and Medical Device and Life Sciences Practice Groups. He has significant experience as outside general counsel advising clients on a variety of business matters related to corporate, commercial, transactional, litigation, and regulatory issues. He handles complex commercial litigation, with an emphasis on representing pharmaceutical, medical device, and other U.S. Food and Drug Administration-regulated companies, solar companies, and hi-tech and new media companies. Peters acts as national and local litigation counsel for companies of all sizes in state and federal courts, including multidistrict litigation and coordinated proceedings. He has recovered significant sums in breach of contract matters as well.
To learn more about the summit or to register, click here.